Galmed Pharmaceuticals (GLMD) Stock Chart & Stock Price History → Special FREE offer on stock hotsheets (From DTI) (Ad) Free GLMD Stock Alerts $0.37 -0.01 (-1.85%) (As of 02:16 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Galmed Pharmaceuticals Stock Price Performance5 Day Performance-11.29%1 Month Performance+18.26%3 Month Performance+10.26%6 Month Performance-13.56%Year-To-Date Performance-18.31%1 Year Performance-92.49% Receive GLMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad DarwinExplore the Future: Unlock the Top 3 AI Stocks for 2024 ReportEager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.) [Get Your Insights Now] GLMD Stock Chart for Friday, April, 19, 2024 GLMD Chart by TradingView Galmed Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$0.36$0.38+5.63%$0.38$0.3727,140 shs$1.91 million04/17/2024$0.35$0.36+2.64%$0.37$0.3446,339 shs$1.80 million04/16/2024$0.38$0.35-8.42%$0.37$0.3396,670 shs$1.76 million04/15/2024$0.42$0.38-9.33%$0.42$0.3690,834 shs$1.92 million04/12/2024$0.42$0.42-0.12%$0.43$0.37163,489 shs$704,000.0004/11/2024$0.41$0.42+1.33%$0.43$0.41161,396 shs$705,000.00 Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$0.39$0.41+6.18%$0.44$0.38301,481 shs$696,000.0004/09/2024$0.39$0.39-0.59%$0.41$0.37324,695 shs$655,000.0004/08/2024$0.34$0.39+15.64%$0.43$0.371.87 million shs$659,000.0004/05/2024$0.33$0.34+3.03%$0.34$0.321.61 million shs$571,000.0004/04/2024$0.33$0.33+0.89%$0.35$0.3233,092 shs$554,000.0004/03/2024$0.32$0.33+0.80%$0.34$0.3242,679 shs$550,000.0004/02/2024$0.33$0.32-0.25%$0.34$0.3250,297 shs$545,000.0004/01/2024$0.35$0.33-6.06%$0.35$0.3289,451 shs$547,000.0003/29/2024$0.33$0.35+5.51%$0.35$0.3241,981 shs$582,000.0003/28/2024$0.34$0.33-3.19%$0.35$0.3241,676 shs$551,000.0003/27/2024$0.32$0.34+4.73%$0.34$0.3216,189 shs$570,000.0003/26/2024$0.32$0.32+0.37%$0.33$0.3255,950 shs$544,000.0003/25/2024$0.31$0.32+3.70%$0.33$0.30136,446 shs$523,000.0003/22/2024$0.32$0.32+0.57%$0.33$0.3163,180 shs$536,000.0003/21/2024$0.30$0.32+4.07%$0.32$0.3155,668 shs$533,000.0003/20/2024$0.31$0.30-3.02%$0.32$0.3077,699 shs$512,000.0003/19/2024$0.31$0.31+1.55%$0.33$0.3080,193 shs$528,000.0003/18/2024$0.31$0.31+1.44%$0.35$0.30301,070 shs$520,000.0003/15/2024$0.35$0.31-12.73%$0.41$0.303.47 million shs$513,000.0003/14/2024$0.36$0.35-3.35%$0.36$0.3290,649 shs$587,000.0003/13/2024$0.36$0.36-0.82%$0.37$0.3521,021 shs$608,000.0003/12/2024$0.38$0.36-3.77%$0.39$0.3634,842 shs$613,000.0003/11/2024$0.38$0.38-0.26%$0.38$0.3737,682 shs$637,000.0003/08/2024$0.38$0.38-0.03%$0.40$0.3711,827 shs$638,000.0003/07/2024$0.37$0.38+2.84%$0.39$0.3724,048 shs$638,000.0003/06/2024$0.38$0.37-2.92%$0.38$0.3647,024 shs$621,000.0003/05/2024$0.40$0.38-3.67%$0.40$0.35126,808 shs$639,000.0003/04/2024$0.41$0.40-3.63%$0.43$0.39158,094 shs$664,000.0003/01/2024$0.40$0.41+2.99%$0.43$0.39204,522 shs$689,000.0002/29/2024$0.41$0.40-2.67%$0.41$0.39103,913 shs$669,000.0002/28/2024$0.39$0.41+5.74%$0.41$0.38160,953 shs$687,000.0002/27/2024$0.37$0.39+4.54%$0.39$0.37163,449 shs$650,000.0002/26/2024$0.36$0.37+2.04%$0.39$0.3644,429 shs$622,000.0002/23/2024$0.36$0.36+0.56%$0.36$0.3631,388 shs$606,000.00Uncover this 2024 Hidden Gem (Ad)Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.[Click here to subscribe] and elevate your trading today.02/22/2024$0.39$0.36-7.24%$0.39$0.34102,763 shs$603,000.0002/21/2024$0.38$0.39+1.90%$0.39$0.3632,334 shs$650,000.0002/20/2024$0.39$0.38-1.45%$0.40$0.3629,662 shs$638,000.0002/19/2024$0.39$0.39+0.01%$0.40$0.3540,200 shs$647,000.0002/16/2024$0.38$0.39+1.55%$0.40$0.3537,938 shs$648,000.0002/15/2024$0.37$0.38+3.15%$0.39$0.3650,196 shs$639,000.0002/14/2024$0.40$0.37-7.55%$0.40$0.34230,519 shs$619,000.0002/13/2024$0.37$0.40+7.73%$0.47$0.351.18 million shs$670,000.0002/12/2024$0.36$0.37+2.81%$0.38$0.3541,621 shs$622,000.0002/09/2024$0.36$0.36+0.93%$0.37$0.3419,630 shs$605,000.0002/08/2024$0.37$0.36-3.18%$0.37$0.3434,198 shs$599,000.0002/07/2024$0.36$0.37+3.75%$0.41$0.35150,172 shs$619,000.0002/06/2024$0.37$0.36-3.98%$0.39$0.3525,556 shs$596,000.0002/05/2024$0.38$0.37-2.97%$0.40$0.35156,833 shs$621,000.0002/02/2024$0.40$0.39-4.44%$0.46$0.37191,220 shs$648,000.0002/01/2024$0.37$0.40+7.74%$0.41$0.35152,281 shs$679,000.0001/31/2024$0.37$0.37+1.05%$0.39$0.3725,649 shs$630,000.0001/30/2024$0.38$0.37-2.30%$0.39$0.3556,758 shs$623,000.0001/29/2024$0.38$0.38+0.33%$0.39$0.3716,714 shs$638,000.0001/26/2024$0.37$0.37+0.59%$0.40$0.3713,319 shs$625,000.0001/25/2024$0.37$0.37$0.40$0.3746,515 shs$622,000.0001/24/2024$0.40$0.37-7.27%$0.40$0.3749,731 shs$622,000.0001/23/2024$0.36$0.40+12.24%$0.40$0.3531,253 shs$670,000.0001/22/2024$0.34$0.36+5.46%$0.37$0.3441,594 shs$597,000.0001/19/2024$0.38$0.34-11.31%$0.39$0.32166,661 shs$566,000.0001/18/2024$0.38$0.38-0.99%$0.40$0.3817,552 shs$639,000.00 Related Companies: PBLA Stock Chart DRMA Stock Chart GRI Stock Chart CMRA Stock Chart INM Stock Chart QLGN Stock Chart LSDI Stock Chart NBSE Stock Chart BPTH Stock Chart CMND Stock Chart Receive GLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLMD) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaMy biggest AI fearParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.